U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
− Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce…
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO
SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug…
New Vizient Survey Finds Drug Shortages Cost Hospitals Nearly $900M Annually in Labor Expenses
IRVING, Texas--(BUSINESS WIRE)--Vizient® today announced its updated analysis of the financial impact…